Meeting of the National Vaccine Advisory Committee, 1998 [E7-553]
Download as PDF
1998
Federal Register / Vol. 72, No. 10 / Wednesday, January 17, 2007 / Notices
desist from the aforementioned alleged
violations of the Act; (b) order PANYNJ
to pay reparations for any violations of
the Act plus interest, costs, attorney’s
fees, and any other damages to be
determined; (c) command PANYNJ to
comply with all applicable provisions of
the Agreement; and (d) any other relief
as the Commission determines to be
proper, fair, and just.
This proceeding has been assigned to
the Office of Administrative Law Judges.
Hearing in this matter, if any is held,
shall commence within the time
limitations prescribed in 46 CFR 502.61,
and only after consideration has been
given by the parties and the presiding
officer to the use of alternative forms of
dispute resolution. The hearing shall
include oral testimony and crossexamination in the discretion of the
presiding officer only upon proper
showing that there are genuine issues of
material fact that cannot be resolved on
the basis of sworn statements, affidavits,
depositions, or other documents or that
the nature of the matter in issue is such
that an oral hearing and crossexamination are necessary for the
development of an adequate record.
Pursuant to the further terms of 46 CFR
502.61, the initial decision of the
presiding officer in this proceeding shall
be issued by January 8, 2008, and the
final decision of the Commission shall
be issued by May 7, 2008.
Bryant L. VanBrakle,
Secretary.
[FR Doc. E7–496 Filed 1–16–07; 8:45 am]
BILLING CODE 6730–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the National Vaccine
Advisory Committee
Department of Health and
Human Services, Office of the Secretary.
ACTION: Notice.
mstockstill on PROD1PC61 with NOTICES
AGENCY:
SUMMARY: As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (DHHS) is hereby giving notice
that the National Vaccine Advisory
Committee (NVAC) will hold a meeting.
The meeting is open to the public.
DATES: The meeting will be held on
February 5, 2007, from 9 a.m. to 5 p.m.,
and on February 6, 2007, from 9 a.m. to
12 p.m.
ADDRESSES: Department of Health and
Human Services; Hubert H. Humphrey
Building, Room 800; 200 Independence
Avenue, SW., Washington, DC 20201.
VerDate Aug<31>2005
13:58 Jan 16, 2007
Jkt 211001
Ms.
Emma English, Program Analyst,
National Vaccine Program Office,
Department of Health and Human
Services, Room 443–H Hubert H.
Humphrey Building, 200 Independence
Avenue, SW., Washington, DC 20201;
(202) 690–5566, nvpo@hhs.gov.
FOR FURTHER INFORMATION CONTACT:
Pursuant
to Section 2101 of the Public Service
Act (42 U.S.C. 300aa–1), the Secretary of
Health and Human Services was
mandated to establish the National
Vaccine Program to achieve optimal
prevention of human infectious diseases
through immunization and to achieve
optimal prevention against adverse
reactions to vaccines. The National
Vaccine Advisory Committee was
established to provide advice and make
recommendations to the Assistant
Secretary for Health, as the Director of
the National Vaccine Program, on
matters related to the program’s
responsibilities.
Topics to be discussed at the meeting
include the 2006–2007 influenza
season, Departmental vaccine priorities,
adolescent and adult immunization,
immunization registry systems, and the
Pandemic and All-Hazards
Preparedness Act. Subcommittee
meetings will be held on the morning of
February 6, 2007. A tentative agenda is
currently available on the NVAC Web
site: https://www.hhs.gov/nvpo/nvac.
Public attendance at the meeting is
limited to space available. Individuals
must provide a photo ID for entry into
the Humphrey Building. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
designated contact person. Members of
the public will have the opportunity to
provide comments at the meeting.
Public comment will be limited to five
minutes per speaker. Any members of
the public who wish to have printed
material distributed to NVAC members
should submit materials to the
Executive Secretary, NVAC, through the
contact person listed above prior to
close of business January 31, 2007. Preregistration is required for both public
attendance and comment. Any
individual who wishes to attend the
meeting and/or participate in the public
comment session should e-mail
nvpo@hhs.gov or call 202–690–5566.
SUPPLEMENTARY INFORMATION:
Dated: January 11, 2007.
Bruce Gellin,
Director, National Vaccine Program Office.
[FR Doc. E7–553 Filed 1–16–07; 8:45 am]
BILLING CODE 4150–44–P
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Childhood
Agricultural Safety and Health
Research, Request for Applications
(RFA) OH–07–002
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting of the
aforementioned Special Emphasis
Panel.
Time and Date: 8 a.m.–5 p.m., February 6,
2007 (Closed).
Place: Residence Inn Marriott, 1456 Duke
Street, Alexandria, Virginia 22314.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of research grant applications in
response to RFA OH–07–002, ‘‘Childhood
Agricultural Safety and Health Research.’’
Contact Person for More Information: Steve
Olenchock, Scientific Review Administrator,
National Institute for Occupational Safety
and Health, 1095 Willowdale Road,
Morgantown, WV 26506, telephone (304)
285–6271.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Elaine Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–506 Filed 1–16–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Proposed Projects
Title: Uniform Project Description
(UPD) Program Narrative for
Discretionary Grant Application Form
OMB No. 0970–0139.
Description: The Administration for
Children and Families (ACF) has more
E:\FR\FM\17JAN1.SGM
17JAN1
Agencies
[Federal Register Volume 72, Number 10 (Wednesday, January 17, 2007)]
[Notices]
[Page 1998]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-553]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the National Vaccine Advisory Committee
AGENCY: Department of Health and Human Services, Office of the
Secretary.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (DHHS) is hereby giving notice
that the National Vaccine Advisory Committee (NVAC) will hold a
meeting. The meeting is open to the public.
DATES: The meeting will be held on February 5, 2007, from 9 a.m. to 5
p.m., and on February 6, 2007, from 9 a.m. to 12 p.m.
ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey
Building, Room 800; 200 Independence Avenue, SW., Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT: Ms. Emma English, Program Analyst,
National Vaccine Program Office, Department of Health and Human
Services, Room 443-H Hubert H. Humphrey Building, 200 Independence
Avenue, SW., Washington, DC 20201; (202) 690-5566, nvpo@hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public
Service Act (42 U.S.C. 300aa-1), the Secretary of Health and Human
Services was mandated to establish the National Vaccine Program to
achieve optimal prevention of human infectious diseases through
immunization and to achieve optimal prevention against adverse
reactions to vaccines. The National Vaccine Advisory Committee was
established to provide advice and make recommendations to the Assistant
Secretary for Health, as the Director of the National Vaccine Program,
on matters related to the program's responsibilities.
Topics to be discussed at the meeting include the 2006-2007
influenza season, Departmental vaccine priorities, adolescent and adult
immunization, immunization registry systems, and the Pandemic and All-
Hazards Preparedness Act. Subcommittee meetings will be held on the
morning of February 6, 2007. A tentative agenda is currently available
on the NVAC Web site: https://www.hhs.gov/nvpo/nvac.
Public attendance at the meeting is limited to space available.
Individuals must provide a photo ID for entry into the Humphrey
Building. Individuals who plan to attend and need special assistance,
such as sign language interpretation or other reasonable
accommodations, should notify the designated contact person. Members of
the public will have the opportunity to provide comments at the
meeting. Public comment will be limited to five minutes per speaker.
Any members of the public who wish to have printed material distributed
to NVAC members should submit materials to the Executive Secretary,
NVAC, through the contact person listed above prior to close of
business January 31, 2007. Pre-registration is required for both public
attendance and comment. Any individual who wishes to attend the meeting
and/or participate in the public comment session should e-mail
nvpo@hhs.gov or call 202-690-5566.
Dated: January 11, 2007.
Bruce Gellin,
Director, National Vaccine Program Office.
[FR Doc. E7-553 Filed 1-16-07; 8:45 am]
BILLING CODE 4150-44-P